Navigation Links
Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone

e company's claims, the risk that the company's product candidates may not achieve market acceptance in North America or elsewhere, the company's reliance on third-party researchers to develop its product candidates, availability of patent protection, the risk that sufficient capital may not be available to develop and commercialize the company's product candidates, and the company's lack of experience in developing and commercializing pharmaceutical products. Additional risks are described in the company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2006. Manhattan Pharmaceuticals assumes no obligation to update these statements, whether as a result of new information, future events, or otherwise, except as required by law.

    Contact information

    Douglas Abel

    President & Chief Executive Officer

    212.582.3950 phone

CONTACT: Douglas Abel, President & Chief Executive Officer of ManhattanPharmaceuticals, Inc., +1-212-582-3950

Web site: http://www.manhattanpharma.com/

Ticker Symbol: (AMEX:MHA)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
4. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
5. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
6. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
7. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
10. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
(Date:7/30/2014)... SAN DIEGO , July 30, 2014  Eisai Inc. ... today that an article based on post-hoc analyses from the ... Loss While on Lorcaserin, Diet, and Exercise as a Predictor ... online issue of Obesity , the official peer reviewed ... was to identify whether there is an early treatment milestone ...
(Date:7/30/2014)... FOREST, Ill., July 30, 2014  Hospira, Inc. ... provider of injectable drugs and infusion technologies, today ... 30, 2014. Net sales for the quarter were ... were $0.72. (Adjusted* measures exclude specified items as ... attached schedules.) On a U.S. Generally Accepted Accounting ...
(Date:7/30/2014)... July 30, 2014 Company ... programming expertise to big data, aerospace and defense, ... eInfochips, a leading engineering R&D services company, today ... NVIDIA GPU-powered solutions for aerospace and defense ... (HPC), industrial , and visual ...
Breaking Medicine Technology:Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30
(Date:7/30/2014)... PA (PRWEB) July 30, 2014 ... Health, is now accepting Highmark Blue Cross Blue ... and licensed dietetic nutritionist, Nourish Nutrition and Health ... of downtown Pittsburgh, in Wexford. , The ... and Health revolve around informing clients on the ...
(Date:7/30/2014)... household income of its residents is the most important factor ... avoidable hospital visits conditions that could be better managed ... treated at an early stage, according to a report released ... , An analysis of hospital billing records and demographic ... Jersey found that as an area,s per capita income rises, ...
(Date:7/30/2014)... NJ (PRWEB) July 30, 2014 Ticket ... Ecuador Tickets at Metlife Stadium in East Rutherford, NJ. ... Brazil will look to get back to their winning ways ... 9 from MetLife Stadium in East Rutherford, N.J. These two ... many years and will continue their feud when they invade ...
(Date:7/30/2014)... high school students by University of Adelaide psychology researchers ... mental health conditions among teens. , School of ... 300 Australian high school students aged 12-18 to better ... time of day they were most active (known as ... journal Sleep Medicine , may have ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Victory ... is proud to announce the launch of a pediatric ... and general surgery. The doctors working in the pediatrics ... of infants, children, and adolescents. Dr. Timothy Cole, Dr. ... Chad McDuffie, Dr. Neelesh Mehendale, and Dr. Nicholas Peiffer ...
Breaking Medicine News(10 mins):Health News:Nourish Nutrition and Health Now Accepting Highmark Insurance 2Health News:Income is a major driver of avoidable hospitalizations across New Jersey 2Health News:Income is a major driver of avoidable hospitalizations across New Jersey 3Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at MetLife Stadium 2Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at MetLife Stadium 3Health News:Teen insomnia is linked with depression and anxiety 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 3
... people with Alzheimer's and psychosis are prone to suffer ... patients with Alzheimer's disease suffer from psychotic symptoms like ... of the condition, linked with more aggressive behaviour, more ... ,Researchers at the Alzheimer's disease Research Center in ...
... people evidence of the harm unhealthy habits do can motivate ... studies on biomarkers indicators of health or disease status ... behaviour. ,They learned that if you reveal factors ... it does encourage people to quit for fear they ...
... people, usually in middle age. People with the disease tend ... not the type of arthritis common in the elderly because// ... system goes awry and attacks the joints, causing severe inflammation ... is also linked to an increased risk of heart disease. ...
... the progress of a catastrophic conditions in organ transplant ... heart transplants develop hardened arteries, a condition// called arteriosclerosis, ... ,A team from the Maryland's Women's Hospital, ... the vitamins during a year-long study. Dr James Fang, ...
... degenerative brain disease that usually begins gradually, causing ... tasks. The disease eventually leads// to confusion, personality ... more difficult as the disease progresses, leaving those ... follow directions. Eventually, most people with Alzheimer’s disease ...
... during pregnancy can increase a mother's risk of having ... were very anxious// in the last three months of ... ,Lead researcher Professor Vivette Glover, of Imperial College, London, ... extreme anxiety, and were frequently feeling scared.According to ...
Cached Medicine News:
Use the Mo Bio Vortex Adapter in conjunction with the Vortex Genie 2 for rapid bead beating procedures. Using the Mo Bio Vortex Adapter is an inexpensive alternative to other bead beating and Fast Pr...
... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Model V-500 is a powerful ... vacuum applications. Applications Ideally suited ... Laboratory vacuum source for instruments including ...
... with Vacuum Controller V-800 Efficiently controls vacuum ... on and off as needed to maintain preset vacuum ... PTFE membrane vacuum pump designed to handle most vacuum ... with up to two rotary evaporators Laboratory ...
... BchiVac V-500 and water-cooled secondary condenser to ... a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with ... Laboratory vacuum source for instruments including vacuum ...
Medicine Products: